Sleep quality and prescription opioid misuse: the potential mediating role of pain intensity, negative affect, and opioid craving

2019 ◽  
Vol 64 ◽  
pp. S152-S153
Author(s):  
A. Herrero Babiloni ◽  
L. Frimerman ◽  
M. Verner ◽  
A. Sirois ◽  
K. Scott ◽  
...  
2014 ◽  
Vol 15 (1) ◽  
pp. 90-100 ◽  
Author(s):  
Marc O. Martel ◽  
Andrew J. Dolman ◽  
Robert R. Edwards ◽  
Robert N. Jamison ◽  
Ajay D. Wasan

2020 ◽  
Vol 55 (10) ◽  
pp. 1601-1609
Author(s):  
Lindsay Pitzer ◽  
Morgane Bennett ◽  
Bethany Simard ◽  
Barbara A. Schillo ◽  
Donna M. Vallone ◽  
...  

2019 ◽  
Vol 204 ◽  
pp. 107456 ◽  
Author(s):  
Daniel J. Paulus ◽  
Andrew H. Rogers ◽  
Jafar Bakhshaie ◽  
Kevin E. Vowles ◽  
Michael J. Zvolensky

Author(s):  
Michael Bakhshesh-Boroujeni ◽  
Sepideh Farajpour-Niri ◽  
Ali karimi

2021 ◽  
pp. 135910532110092
Author(s):  
Dylan G Serpas ◽  
Laura Zettel-Watson ◽  
Barbara J Cherry

This study investigated the mediating role of depressive symptoms among 147 middle-aged and older adults with FM in the relationship between pain intensity and 4 objective measures of physical performance: Fullerton Advanced Balance scale (FAB), 6-Minute Walk Test (6MWT), 30-Second Chair Stand (30SCS), and 8-Foot Up and Go Test (8FUPGT). Asymptotic mediation analyses revealed that depressive symptoms fully mediated the relationship between pain intensity and FAB (95% CI [−0.40, −0.10]) and 8FUPGT (CI [0.02, 0.11]) and partially mediated the relationship to 6MWT (CI [−9.15, −2.20]) and 30SCS (CI [−0.29, −0.06]). Findings support the evaluation of co-morbid depression in FM.


2021 ◽  
pp. 1-18
Author(s):  
Andréanne Angehrn ◽  
Kelsey D. Vig ◽  
Julia E. Mason ◽  
Andrea M. Stelnicki ◽  
Robyn E. Shields ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document